Global $46 Billion Digital Biomarker Market Outlook to 2030: Neurodegenerative Disorders Segment is Expected to Grab the Largest Market Revenue of Over $11 Billion

News provided by

Nov 18, 2021, 12:00 ET

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Digital Biomarker Market Outlook 2030" report has been added to ResearchAndMarkets.com's offering.

The market garnered a revenue of around USD 1040 Million in the year 2019 and is further projected to reach over USD 46000 Million by the end of 2030.The global digital biomarker market is anticipated to grow with a CAGR of 41.22% during the forecast period, i.e., 2020-2030.

Digital biomarkers are consumer generated physiological and behavioral measures that are collected through connected digital devices. The collected data is then used to explain, influence or predict health related outcomes of an individual.

Factors such as the growing adoption of mobile health applications, increasing number of internet users, growing adoption of smartphone worldwide, and the rise in awareness amongst individuals for maintaining a good health, are anticipated to drive the market growth.

On the basis of system component, the market is segmented into data collection tools and data integration systems, out of which, the data integration systems segment is expected to grow with the highest CAGR of about 42% during the forecast period.

The market is also segmented on the basis of therapeutic area into cardiovascular diseases, neurodegenerative disorders, sleep & movement diseases, psychiatric disorders, chronic pain, gastrointestinal diseases, diabetes, respiratory conditions, and others, out of which, the neurodegenerative disorders segment is expected to grab the largest market revenue of over USD 11800 Million by the end of 2030.

On the basis of regional analysis, the market is segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa, out of which, the market in North America is expected to leading market share throughout the forecast period and further garner a market revenue of close to USD 21 Million by 2030.

Some of the prominent industry leaders in the global digital biomarker market are

ActiGraph LLC
Akili Interactive Labs Inc.
AliveCor Inc.
Altoida Inc.
Biogen Inc.
ConnectedLife Health Pte Ltd
Cambridge Cognition Ltd
Evidation Health Inc.
Fitbit Inc.
Happify Inc.
Human API
GlaxoSmithKline plc
Huma
IXICO plc
Kinsa Inc.
Koneksa
Medical Care Corporation
Mindstrong Health
Koninklijke Philips N.V.
Neurotrack Technologies Inc.
Novartis AG
ResMed
F. Hoffmann-La Roche Ltd
Winterlight Labs
Verily Life Sciences LLC

Key Topics Covered:

1. Market Introduction

2. Research Methodology

3. Executive Summary - Global Digital Biomarker Market

4. Pathway to Regulatory Approval of Digital Biomarkers

5. Analysis of Market Dynamics

6. COVID-19 Impact Analysis on the Global Digital Biomarker Market

7. PORTER'S Five Forces Analysis on the Global Digital Biomarker Market

8. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples

9. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets

10. World Mobile Data Traffic by Deployment Mode & Traffic by Device

11. Current Challenges of Digital Biomarkers in Medical Settings

For more information about this report visit https://www.researchandmarkets.com/r/tdjzvn

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets